Trial intelligence / Profile preview

Cardiac BabySPICE pilot trial of dexmedetomidine versus midazolam after infant congenital heart surgery

ACTRN12615001304527Phase 2Completed

Sponsor
Paediatric Critical Care Research Group
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial in Cardiovascular Malformation (CVM) comparing Dexmedetomidine primary sedation with Midazolam usual practice control (2 arms). Primary endpoint: Feasibility of screening and recruitment. Started Apr 2017; status: completed.

02

Drugs

dexmedetomidinemidazolam
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on ACTRN12615001304527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615001304527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call